Omega Therapeutics's market cap is currently $8.53M. The company's EPS TTM is $-1.325; its P/E ratio is ―; Omega Therapeutics is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.24. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 3.09M	$ 2.07M	$ 144.00K	$ 0.00	$ 0.00
Gross Profit	$ -62.77M	$ -3.12M	$ -1.24M	$ -1.15M	$ -794.00K
Operating Income	$ -100.26M	$ -102.77M	$ -66.03M	$ -28.64M	$ -17.34M
EBITDA	$ -93.49M	$ -97.58M	$ -64.64M	$ -27.50M	$ -16.55M
Net Income	$ -97.43M	$ -102.64M	$ -69.16M	$ -30.20M	$ -18.53M
Balance Sheet
Cash & Short-Term Investments	$ 73.43M	$ 70.61M	$ 225.33M	$ 22.95M	$ 2.27M
Total Assets	$ 204.37M	$ 146.00M	$ 233.33M	$ 28.08M	$ 6.12M
Total Debt	$ 128.43M	$ 22.58M	$ 19.87M	$ 11.73M	$ 11.89M
Net Debt	$ 59.98M	$ -48.03M	$ -166.61M	$ -11.22M	$ 9.62M
Total Liabilities	$ 146.35M	$ 40.03M	$ 32.70M	$ 92.71M	$ 42.04M
Stockholders' Equity	$ 58.02M	$ 105.97M	$ 200.63M	$ -64.63M	$ -35.92M
Cash Flow
Free Cash Flow	$ -94.38M	$ -99.89M	$ -59.08M	$ -27.94M	$ -16.56M
Operating Cash Flow	$ -91.51M	$ -98.52M	$ -57.61M	$ -26.13M	$ -15.68M
Investing Cash Flow	$ 47.52M	$ -18.06M	$ -40.40M	$ -1.81M	$ -885.00K
Financing Cash Flow	$ 41.82M	$ 708.00K	$ 261.54M	$ 48.62M	$ 11.98M

Currency in USD

Omega Therapeutics Earnings and Revenue History

Income Statement >

Omega Therapeutics Debt to Assets

Balance Sheet >

Omega Therapeutics Cash Flow

Cash Flow >

Omega Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing